“Improving prescription drug affordability for Medicare enrollees is the core of the Inflation Reduction Act, and the next ...

As part of the Inflation Reduction Act, price negotiations with manufacturers will begin this year, with reduced prices ...

The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started ...

The Health and Human Services Department won’t issue health advisories, reports or other materials until further notice, the ...

As of Monday, FDA commissioner Robert Califf, Department of Health and Human Services (HHS) Secretary Xavier Becerra, ...

Meena Seshamani’s Medicare swan song ended on a note of bravura: the announcement that 15 costly drugs, including Novo ...

Experts suggest that most Americans will not experience immediate changes in their out-of-pocket health care expenses.

The talks around drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices ...

Abe Sutton, a health policy aide in the first Trump administration, is likely to be named head of the Center for Medicare and ...

Drugs used to treat cancer, diabetes and other chronic conditions are among 15 picked for negotiations that could result in ...

On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...

Paul Mango, a senior health official during President-elect Donald Trump's first term who was a member of Trump's current ...